CLINICAL_TRIALS
trial_result
· 2019-01-03
Clinical Trial Update: Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy, safety, and tolerability of oral ubrogepant for acute treatment of migraine has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Migraine, With or Without Aura | Phase 3 | Status: COMPLETED | Results posted: 2019-01-03